Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction.

Balta S, Demirkol S, Arslan Z, Demir M, Unlu M, Kucuk U.

Ups J Med Sci. 2014 Mar;119(1):57. doi: 10.3109/03009734.2013.851749. Epub 2013 Nov 6. No abstract available.

2.

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease.

Dogru T, Sertoglu E, Celebi G, Gurel H, Ercin CN.

Ups J Med Sci. 2014 Mar;119(1):58-9. doi: 10.3109/03009734.2013.852276. Epub 2013 Dec 13. No abstract available.

3.

Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis.

Sarli B, Arinc H, Baktir AO, Saglam H, Demirci E.

Ups J Med Sci. 2014 Mar;119(1):60-1. doi: 10.3109/03009734.2013.852275. Epub 2013 Nov 18. No abstract available.

4.

Endothelial dysfunction in patients with non-alcoholic steatohepatitis.

Onal IK.

Ups J Med Sci. 2014 Aug;119(3):290-1. doi: 10.3109/03009734.2013.872736. Epub 2014 Jan 7. No abstract available.

5.

Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.

Arinc H, Sarli B, Baktir AO, Saglam H, Demirci E, Dogan Y, Kurtul S, Karaman H, Erden A, Karaman A.

Ups J Med Sci. 2013 Nov;118(4):228-34. doi: 10.3109/03009734.2013.814734. Epub 2013 Jul 8.

7.

[Diagnostic relevance of the De Ritis quotient and gamma-glutamyltransferase in alcoholic liver parenchyma damage].

Kilger B, Baumgarten R, Fengler JD, Bartke D.

Z Arztl Fortbild (Jena). 1986;80(10):405-6. German. No abstract available.

PMID:
2875568
8.

Liver enzymes: potential cardiovascular risk markers?

Lioudaki E, Ganotakis ES, Mikhailidis DP.

Curr Pharm Des. 2011 Nov;17(33):3632-43. Review.

PMID:
22074433
9.

An obese 14-year-old girl with persistently elevated liver-associated enzymes.

Shaffer RT, Carrougher JG, Kadakia SC, Goodman ZD.

Semin Liver Dis. 1992 Nov;12(4):429-34. No abstract available.

PMID:
1361243
10.

Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.

Loguercio C, De Simone T, D'Auria MV, de Sio I, Federico A, Tuccillo C, Abbatecola AM, Del Vecchio Blanco C; Italian AISF Clinical Group.

Dig Liver Dis. 2004 Jun;36(6):398-405.

PMID:
15248380
11.

Re: The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.

Cox-North PP.

J Am Board Fam Med. 2009 May-Jun;22(3):339. doi: 10.3122/jabfm.2009.03.080247. No abstract available.

12.

Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.

Ayala I, Castillo AM, Adánez G, Fernández-Rufete A, Pérez BG, Castells MT.

Exp Biol Med (Maywood). 2009 Jan;234(1):10-6. doi: 10.3181/0807-RM-219. Epub 2008 Nov 7.

PMID:
18997102
13.

Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease.

Franzini M, Fornaciari I, Fierabracci V, Elawadi HA, Bolognesi V, Maltinti S, Ricchiuti A, De Bortoli N, Marchi S, Pompella A, Passino C, Emdin M, Paolicchi A.

Liver Int. 2012 Apr;32(4):629-34. doi: 10.1111/j.1478-3231.2011.02673.x. Epub 2011 Nov 4.

PMID:
22098947
14.

Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?

Hickman IJ, Russell AJ, Prins JB, Macdonald GA.

Diabetes Res Clin Pract. 2008 Apr;80(1):e10-2. doi: 10.1016/j.diabres.2007.11.016. Epub 2008 Jan 9.

PMID:
18187226
15.

Body mass index and waist circumference in non-alcoholic fatty liver disease.

Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA.

J Hum Nutr Diet. 2005 Oct;18(5):365-70.

PMID:
16150132
16.

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.

Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A.

Aliment Pharmacol Ther. 2001 Oct;15(10):1667-72.

17.

[HIV and the liver].

Cadranel JF, Wendum D, Pialoux G.

Gastroenterol Clin Biol. 2001 Jan;25(1):93-6. French. No abstract available.

18.

A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels.

Shen Z, Li Y, Yu C, Shen Y, Xu L, Xu C, Xu G.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):820-5. doi: 10.1097/MEG.0b013e3283328b86.

PMID:
19829121
19.

Liver function tests as indicators of metabolic syndrome.

Lee HC.

Korean J Hepatol. 2011 Mar;17(1):9-11. doi: 10.3350/kjhep.2011.17.1.9. No abstract available.

20.

[Research on the relationship between non-alcoholic fatty liver disease and platelet phospholipid fatty acids].

Yu XM, Li D, Xie HB, Wang Q, Xu AM, Bi QH, Ye XW, Fan FH.

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):225-6. Chinese. No abstract available.

PMID:
19335990

Supplemental Content

Support Center